We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

A glowing AI symbol surrounded by futuristic digital icons representing artificial intelligence, data security, cloud computing, and automation, hovering over an open human hand.
Industry Insight

AI Is Redefining the Role of the Scientist – Here’s How

The integration of AI and automation is transforming laboratory research, improving overall efficiency and scalability. However, scientists must be cautious as over-reliance on AI may weaken critical thinking and troubleshooting skills.
A doctor in a white coat with a stethoscope stands with arms crossed in a high-tech medical environment. Digital graphics overlay the image, featuring AI-related symbols, a human body outline, data visualizations and futuristic medical icons.
Industry Insight

AI’s Next Horizon: Cell and Gene Therapy Manufacturing

Dalip Sethi provides valuable insights on how AI is currently being carefully and critically considered within the cell and gene therapy industry, with regard to data and technological preparedness.
Illustration of CAR T-cells attacking a cancer cell, representing immunotherapy in cancer treatment.
Industry Insight

Overcoming CAR T-Cell Therapy Limitations

In an interview with Arthur Stril, chief business officer and interim CFO at Cellectis, we explore how gene editing and innovative manufacturing strategies are overcoming the key limitations of autologous CAR T-cell therapy.
Three scientists in white lab coats discussing research findings in a modern flow cytometry laboratory.
Industry Insight

Flow Cytometry Advancements Accelerate Drug Discovery

A specialist in flow cytometry, cell sorting and cellular biology, Dr. Richard Cuthbert shared his perspectives on the current and future applications of flow cytometry – and automated flow cytometry systems – in modern drug discovery.
A group of stem cells, a key component of stem cell therapies.
Industry Insight

Bridging the Gap Between Stem Cell Therapy Research and Clinical Trials

Dr. Bo Wiinberg, chief business development officer at the Novo Nordisk Foundation Cellerator, discusses the current obstacles halting advances in stem cell-based cell therapies and what can be done to overcome them.
A man in a mask recieving a vaccine, a crucial part of pandemic preparedness.
Industry Insight

T-Cell Priming Technology Strengthens Pandemic Preparedness

Technology Networks spoke to Professor Thomas Rademacher, co-founder, executive director and CEO at Gylden Pharma Limited, to learn more about T-cell priming vaccine technology and its potential to strengthen preparedness for future pandemics.
Digital visualization of brain cell networks with colorful neural connections and synapses.
Industry Insight

Simplifying Cell Visualization in Complex Model Systems

bit.bio’s GFP ioMicroglia enables real-time tracking of microglia in complex co-cultures and in vivo, streamlining neurodegeneration research and drug discovery.
Gloved scientist pipetting samples for flow cytometry analysis.
Industry Insight

Advancing Flow Cytometry With High-Throughput Analysis and Automation

Technology Networks spoke with Dr. Richard Cuthbert, cell biology product manager at Bio-Rad, to learn more about Bio-Rad's new ZE5 Cell Analyzer, the challenges within the field and recent technological advancements in flow cytometry.
Young girl with a rare disease undergoing a medical checkup, accompanied by her mother and a stuffed toy for comfort.
Industry Insight

Tackling Rare Diseases With RNA Therapeutics

To learn about the progress being made in the RNA therapeutics space, we spoke to CTO and Co-Founder of La Jolla Labs, Jeff Milton, at the 2025 SLAS international meeting in San Diego.
Scientist holding a tablet with a virtual display showing an image of AI and a human.
Industry Insight

Going Mobile in the Lab

Labs have been using "mobile devices" – paper and pencil – for centuries. Now it's time to embrace "modern" mobile devices.
Advertisement